Podcasts about ZT

Marion haar online training vind je op: http://voeljeverlangen.nu Meer op http://heel-gelukkig.nu Dit gesprek in video: https://youtu.be/ZT-z-fWMxTE

On the mid-week supplemental episode of The Knife Junkie podcast (episode 564), Bob "The Knife Junkie" DeMarco looks at several great fixed blade field knives, including the Buck 119, TOPS Tex Creek, and Station IX S.E.R.E., among others.Bob begins with his favorite comment of the week.In his pocket check of knives, it's the Microtech SOCOM Elite, JWK After Hours Jack, Hogtooth Knives Ruffian, and the Pepperwool Merino MM (Emotional Support Knife).In Knife Life News:• TOPS Shows Off a New One in the Offing• We Knife Co.'s New Quinseris is a Four Inch Bladed Beauty• Lots of Cool New Ones from Kershaw in 2025• ZT is Turning Heads with a New Auto and EDC FlipperMeanwhile, in his State of the Collection, Bob looks at the Station IX Number Twelve, TOPS Modern Gladius (Foster Knife - Thanks Dave), and the Cold Steel Laredo Bowie Trainer.Find the list of all the knives shown in the show and links to the Knife Life news stories at https://theknifejunkie.com/564.Support the Knife Junkie channel with your next knife purchase. Find our affiliate links at https://theknifejunkie.com/knives. You can also support The Knife Junkie and get in on the perks of being a patron, including early access to the podcast and exclusive bonus content. Visit https://www.theknifejunkie.com/patreon for details.Let us know what you thought about this episode and leave a rating and/or a review. Your feedback is appreciated. You can also email theknifejunkie@gmail.com with any comments, feedback, or suggestions.To watch or listen to past episodes of the podcast, visit https://theknifejunkie.com/listen. And for professional podcast hosting, use The Knife Junkie's podcast platform of choice: https://theknifejunkie.com/podhost.

Jean-Marie Le Pen byl po desetiletí a stále zůstává temnou figurou francouzské politiky, symbolem krajní pravice. Ztělesňoval všechny její nejhorší stránky: obdiv k nacismu a italskému fašismu, kontakty s bývalými nacistickými kolaboranty včetně členů SS, popírání vyvražďování Židů, otevřený antisemitismus, násilnictví, provokace, urážky, skandály, jež měly soudní dohry a tresty. A později neustálé strašení přistěhovalectvím.Všechny díly podcastu Názory a argumenty můžete pohodlně poslouchat v mobilní aplikaci mujRozhlas pro Android a iOS nebo na webu mujRozhlas.cz.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: A push to change the defined stages of T1D, InsuJet is approved in Canada, new study linked T2D and dementia, new drug looked at to prevent hypoglycemia, big honors for a T1D author and more! Our interview with Clare Edge here.  Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:     Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX   The understanding of type 1 has changed a lot in the last 10-15 years, specifically with the definition of stages of the disease. Now some researchers suggest the current 2015 model is ready for another update. University of Florida Health diabetes researchers and collaborators last week issued a call to action in The Lancet Diabetes & Endocrinology, urging the development of a more precise method of calculating type 1 diabetes risk. Under the current staging system, this is Stage 1 of the disease, when a patient does not yet have elevated blood sugar but has two or more of these autoantibodies in the blood. Stage 2 is diagnosed when blood sugar begins to rise, indicating a dysfunctional pancreas in a patient who does not yet have clinical type 1 diabetes. That comes in Stage 3 with high blood sugar and, eventually, the classic symptoms of the disease, including frequent urination, weight loss and fatigue. Jacobsen, however, said the staging system requires more precision. This is especially important as the current staging model determines if a patient is eligible to receive a drug therapy called teplizumab, the only Food and Drug Administration-approved medication that can delay the onset of type 1 diabetes by an average of two years. The staging system, however, does not include a patient's age and these researchers say additional markers that would be important to consider include a greater array of abnormal metabolic measures beyond blood sugar and the presence of more autoantibodies.   https://www.gainesville.com/story/news/healthcare/2024/12/04/uf-health-scientists-propose-update-to-type-1-diabetes-staging-system/76734459007/ XX A product called InsuJet gets approval in Canada. Made by NuGen Medical Devices, InsuJet™ is a needle-free injection system. It's already approved for sale in 42 countries – not yet the US. Their website says InsuJet's jet-injected fluid penetrates the skin through a small orifice of a special nozzle, creating a thin, high pressure stream. This way, insulin doesn't remain around the place of injection, like it does with a needle. Instead, with InsuJet, the insulin is deposited into the subcutaneous tissue where it's easily absorbed and acts faster– saving you money, time, and discomfort.   https://finance.yahoo.com/news/nugen-announces-canada-wide-launch-221500674.html XX Individuals diagnosed with type 2 diabetes before the age of 50 may be at a higher risk of developing dementia later in life. A study led by researchers at NYU Rory Meyers College of Nursing, says the risk is notably greater among adults with obesity. Type 2 diabetes is a known risk factor for dementia. Although the underlying mechanisms are not fully understood, scientists think that some of the hallmarks of diabetes—such as high blood sugar, insulin resistance, and inflammation—may encourage the development of dementia in the brain.     The researchers note that this greater understanding of the connection between diabetes onset, obesity, and dementia may help inform targeted interventions to prevent dementia. https://scitechdaily.com/diagnosed-young-with-diabetes-your-dementia-risk-may-be-higher/ XX Embecta is out of the insulin patch pump business – just months after getting the ok from the FDA. Embecta received FDA clearance for its insulin patch pump in September. The device is indicated for people with Type 1 or Type 2 diabetes and includes a 300-unit insulin reservoir to support people with higher daily insulin needs. However, the version Embecta received clearance for was an open-loop patch pump, where users manually control insulin delivery, while the firm's goal was to develop a closed-loop version, which automatically delivers insulin when needed. The CEO also expects competition in closed-loop devices for people with Type 2 diabetes to intensify, with Insulet receiving FDA clearance for its Omnipod 5 patch pump for Type 2 diabetes in August. https://www.medtechdive.com/news/embecta-discontinue-patch-pump/734059/ XX Sanofi invests in a company developing a new drug to prevent hypoglycemia. We reported on Zucara Therapeutics back in 2022 and they've been moving ahead with ZT-01. ZT-01 is a medication being developed to help prevent dangerous low blood sugar (hypoglycemia) by fixing how the body normally fights it. In people without diabetes, a hormone called glucagon is released to raise blood sugar when it gets too low. But in people with insulin-dependent diabetes, like type 1 diabetes or some forms of type 2 diabetes, this process doesn't work well because another hormone, somatostatin (SST), blocks glucagon from being released. ZT-01 works by blocking the effects of somatostatin, allowing the body to release more glucagon when it's needed. This could help people with diabetes avoid severe low blood sugar episodes.   https://www.prnewswire.com/news-releases/zucara-therapeutics-announces-strategic-investment-from-sanofi-as-part-of-us20-million-series-b-financing-302301820.html XX Omnipod 5 is now compatible with the FreeStyle Libre 2 plus. The company says the recent development “ makes Omnipod 5 the most connected tubeless AID system in the U.S.” It's already compatible with Dexcom's G6 and G7 CGMs. https://www.businesswire.com/news/home/20241120268759/en/Insulet-Announces-Omnipod%C2%AE-5-System-is-Now-Compatible-with-Abbott%E2%80%99s-FreeStyle-Libre-2-Plus-Sensor-in-the-U.S. XX A new study involving 11 clinical centers across the United States aims to uncover how type 1 diabetes (T1D) impacts brain health and cognitive function in children. Led by the Keck School of Medicine of the University of Southern California, this is a five-year study to explore critical questions about how environmental, lifestyle, social and clinical factors affect brain development during childhood — a period crucial for cognitive growth. https://www.managedhealthcareexecutive.com/view/new-study-to-explore-impact-of-type-1-diabetes-on-children-s-brain-development XX Dexcom looking to partner with smart ring company Oura. Originally launched to track sleep patterns, the latest Oura technology collects more than 20 biometrics ranging from heart rate and activity metrics to sleep and body temperature monitoring. The companies say the new partnership is intended to provide users with seamless integration between the two ecosystems so shared users can track their glucose levels and understand the impact of behaviors and biology on their metabolic health. https://www.forbes.com/sites/saibala/2024/11/29/smart-ring-maker-oura-hits-5-billion-in-valuation--strikes-major-partnership-with-dexcom/ XX   WEDNESDAY, Dec. 4, 2024 (HealthDay News) -- Taking even high doses of supplementary vitamin D won't lower an older person's odds for type 2 diabetes, new research confirms. They published their findings Dec. 2 in the journal Diabetologia. The new research followed on data from other studies that had suggested that people with especially low levels of vitamin D might face a higher risk for diabetes. That was true for people who were already prediabetic, especially. To find out, researchers led by Jirki Vyrtanen, from the University of Eastern Finland, randomly assigned nearly 2,300 people aged 60 or older to receive either placebo pills or 40 or 80 micrograms of vitamin D3 supplements per day, for five years.  At the end of the five years, "105 participants developed type 2 diabetes: 38 in the placebo group, 31 in the group receiving 40 micrograms of vitamin D3 per day, and 36 in the group receiving 80 micrograms of vitamin D3 per day," according to a university news release. In other words, there were no significant differences in the rate at which people developed type 2 diabetes, regardless of how much supplemental vitamin D they took. Vytanen's team also saw no benefit from high-dose supplements on a person's blood sugar or insulin levels, or measures of overweight/obesity. The bottom line, according to the researchers: For any healthy, non-prediabetic person with healthy vitamin D levels, upping intake of the vitamin won't alter your odds for diabetes or its common risk factors. https://www.usnews.com/news/health-news/articles/2024-12-04/high-dose-vitamin-d-supplements-wont-prevent-diabetes-in-healthy-seniors XX Big congrats to author Clare Edge – recent guest on the podcast. Her book, Accidental Demons is featured on People Magazine's top ten book gift suggestions for this year! Whether you're looking for books about winter and the holidays, a primer on some of this year's buzziest musicians and characters or that "one more chapter" kind of bedtime favorite, there's sure to be a book out there to suit their taste. Bernadette Crowley, also known as Ber, comes from a long line of witches. When Ber is diagnosed with diabetes, however, she learns that every time she tests her blood sugar, demons accidentally slip into the human dimension — and it's up to Ber and her sister, Maeve, to stop them. This fantastical book is a great escape for young readers over holiday break. Buy Now Top ten books https://people.com/kids-gift-book-suggestions-wicked-taylor-swift-books-8752097

Die Folg ligt mer ganz bsundrig am Härz! Sit über 15 Jahr si zTäbi u ig befründet! Umso schöner, dass sie mit mir isch a Tisch ghocket und so ehrlech u offe verzellt het! Mir redä übers "Guet Gnueg sii" i Fründ*inneschafte, was mer i all dene Jahr hei glehrt, was mer anenang schetzä u wieso mer o nach Toucher, geng no so äng u so töif wie no nie befründet si. Die Folg isch es Bijoux i säge nechs! dTabea uf Insta: https://www.instagram.com/beijeee/ üses Finel-Retreat: https://www.sarahluisaiseli.com/retreats

On the mid-week supplemental episode of The Knife Junkie podcast (episode 550), Bob "The Knife Junkie" DeMarco looks at 10 great machetes in his collection, including the Schrade Delta Class Decimate, Condor Golok, and the Cold Steel Axis Machete, among others.Bob begins with his favorite comments of the week.In his pocket check of knives, it's the Monterey Bay Knives Turbo, C.Risner Ohio River Jack, Hogtooth/TKJ NoVA-1, and the Orion Ares (Emotional Support Knife).In Knife Life News:• Kershaw Drops Some New Ones But This is the Coolest• New TOPS Tundra Wolf Collaboration with Trevor Barrett• Becker BK2 is Testbed for Ka-Bar's Plunge Into Magnacut• A New Auto and Fixie from ZT!Meanwhile, in his State of the Collection, Bob looks at his new Pepperwool Merino MM (thanks Beren!) and the Fisher Blades Beckwith Covert FDE.Find the list of all the knives shown in the show and links to the Knife Life news stories at https://theknifejunkie.com/550.Support the Knife Junkie channel with your next knife purchase. Find our affiliate links at https://theknifejunkie.com/knives. You can also support The Knife Junkie and get in on the perks of being a patron, including early access to the podcast and exclusive bonus content. Visit https://www.theknifejunkie.com/patreon for details.Let us know what you thought about this episode and leave a rating and/or a review. Your feedback is appreciated. You can also call the listener line at 724-466-4487 or email theknifejunkie@gmail.com with any comments, feedback, or suggestions.To watch or listen to past episodes of the podcast, visit https://theknifejunkie.com/listen. And for professional podcast hosting, use The Knife Junkie's podcast platform of choice: https://theknifejunkie.com/podhost.

Jak vypadá dohoda ministra zdravotnictví Vlastimila Válka (TOP 09), ambulantních specialistů a pojišťoven, která odvrátila dvoudenní protest lékařů? Ztíží novela, kterou schválili poslanci, přístup ke zbraním pro labilní osoby? A proč ukrajinský prezident Volodymyr Zelenskyj odmítá setkání s generálním tajemníkem OSN po tom, co António Guterres jednal o možném uzavření míru s Ruskem? Poslechněte si celou odpolední publicistiku s Věrou Štechrovou.

Jak vypadá dohoda ministra zdravotnictví Vlastimila Válka (TOP 09), ambulantních specialistů a pojišťoven, která odvrátila dvoudenní protest lékařů? Ztíží novela, kterou schválili poslanci, přístup ke zbraním pro labilní osoby? A proč ukrajinský prezident Volodymyr Zelenskyj odmítá setkání s generálním tajemníkem OSN po tom, co António Guterres jednal o možném uzavření míru s Ruskem? Poslechněte si celou odpolední publicistiku s Věrou Štechrovou.Všechny díly podcastu Hlavní zprávy - rozhovory a komentáře můžete pohodlně poslouchat v mobilní aplikaci mujRozhlas pro Android a iOS nebo na webu mujRozhlas.cz.

On the mid-week supplemental episode of The Knife Junkie podcast (episode 535), Bob "The Knife Junkie" DeMarco looks at several of the Big Bad Bowies in his collection, including the Ontario SP-10 Raider, Cold Steel Western, and the Cudemon JBK-1. among others.Bob begins with his favorite comments of the week.In his pocket check of knives, it's the ZT 0620, JWK Benny's Clip, Pinkerton Fireant Custom, and the Cold Steel TiLite VI (Emotional Support Knife).Bob also highlights the September 2024 Gentleman Junkie giveaway knife: the Colorful Filth/Northern Knives Demko AD-20.5.In Knife Life News:• Multifunction Button Lock Coming from Civivi• Artisan Cutlery Has Kickstarter for New Designer's Folder• Pocket Nessmuk Out from Boker and Matthew Gentry• Another EDC Fixie from Ostap Hel and Real SteelMeanwhile, in his State of the Collection, Bob looks at the Corona 10-inch Razor Tooth Saw.Find the list of all the knives shown in the show and links to the Knife Life news stories at https://theknifejunkie.com/535.Support the Knife Junkie channel with your next knife purchase. Find our affiliate links at https://theknifejunkie.com/knives. You can also support The Knife Junkie and get in on the perks of being a patron, including early access to the podcast and exclusive bonus content. Visit https://www.theknifejunkie.com/patreon for details.Let us know what you thought about this episode and leave a rating and/or a review. Your feedback is appreciated. You can also call the listener line at 724-466-4487 or email bob@theknifejunkie.com with any comments, feedback, or suggestions.To watch or listen to past episodes of the podcast, visit https://theknifejunkie.com/listen. And for professional podcast hosting, use The Knife Junkie's podcast platform of choice: https://theknifejunkie.com/podhost.

Studiogespräch mit der noroomgallery unter Einschluß von https://www.freie-radios.net/130575. http://www.noroomgallery.com/ z.Zt. mit dem Projekt boxing the city.

This week Ben and Jay are joined by AMD's EVP of Datacenter Solutions Forrest Norrod. AMD's acquisition of ZT Systems is a strategic move to enhance its position in the data center and AI market. ZT Systems is a leading systems design company focused on hyperscalers, with expertise in customized server and rack designs. By integrating ZT's design capabilities with AMD's silicon and software engineering, AMD aims to create better and more optimized AI server solutions. The acquisition also allows AMD to accelerate time-to-market and support their customers in deploying AI systems faster. AMD plans to divest the manufacturing side of ZT Systems and continue to collaborate with OEM and ODM partners.

Jackson Hole ECO Confab (this week) Live Nation is in trouble Icahn get a slap on the wrist Gold - ripping - where to next? PLUS we are now on Spotify and Amazon Music/Podcasts! Click HERE for Show Notes and Links DHUnplugged is now streaming live - with listener chat. Click on link on the right sidebar. Love the Show? Then how about a Donation? Follow John C. Dvorak on Twitter Follow Andrew Horowitz on Twitter DONATIONS ? Warm Up - Jackson Hole ECO Confab (this week) - Live Nation is in trouble - Icahn get a slap on the wrist - Gold - ripping - where to next? - Price Controls - 3rd Rail? Market Update - Nearing all-time highs again - Buy the Dips! - Yields under 4% on 10-Year - Yen still in control - Back to Overbought again - still thinking not out of the woods - Lowe's and Home Depot Outlook - POOR (But stocks are up) Jackson Hole - Aristocrats line up to speak - Big doings as often a platform for Fed and other central bankers to make policy adjustments - Powell scheduled to speak at 10am Friday --- With all of the latest data and market push - what will he do?? - Before that - Wednesday we will see the July FOMC minutes GOLDDDDDDDD - Gold hit all-time high last Friday ($2,509.65) !!!!NOW $2,563!!!!! - WHY? Discussion ranges from Fed Reserve, Election, Middle East, India Buying.... - Gold has been a better GOLD then Bitcoin - just saying... Monopoly - Finally! - Ten Additional States Join Justice Department's Suit Against Live Nation-Ticketmaster for Monopolizing Markets Across the Live Concert Industry - Today, the Attorneys General of Indiana, Iowa, Kansas, Louisiana, Mississippi, Nebraska, New Mexico, South Dakota, Utah and Vermont joined a civil antitrust lawsuit filed by the Justice Department, 29 other states and the District of Columbia against Live Nation-Ticketmaster for monopolization and other unlawful conduct in violation of Sections 1 and 2 of the Sherman Act. - Stock does not seem to care - or believe anything adverse will happen AMD buys ZT Systems - $4.9 Billion - What is ZT Systems? The company engages in full rack deployment -- a block filled with servers, storage, switches, etc. -- for hyperscale data centers. ZT also commands a data center infrastructure manufacturing business, for which AMD announced it would seek out a strategic partner to offload this part of the company. - Clearly the company does not have a CHIP or infrastructure  ready for a major AI play at this time. Carl Ichan - Hand Slap - Carl Icahn and his publicly traded company Icahn Enterprises settled with the SEC over allegedly failing to disclose billions worth in stock-backed borrowing. - Icahn and IELP will pay a combined $2 million in fines, without admitting or denying wrongdoing, over the failure to disclose as much as $5 billion in margin loans that were backed by Icahn's stake in the company. - Icahn, a well-known activist investor, had been facing pressure from another activist short seller in 2023. (Hindenburg which is still short the shares) Circle K 11? - Canada's Alimentation Couche-Tard (Circle K) has sounded out Japan's Seven & i (7-Eleven) about a potential takeover, the two companies said on Monday, making the 7-Eleven owner the largest-ever Japanese target of a foreign buyout. - While the value of the offer has not been disclosed, the bid is the latest example of the growing interest in Japanese companies by Western investors, who have been drawn by the country's push for better governance. - News of the deal sent shares of Seven & i surging by almost 23% in Tokyo Chicken and the Egg - Chicken prices are going up - Perdue Foods is recalling more than 167,000 pounds of frozen chicken nuggets and tenders after some customers reported finding metal wire embedded in the products. - According to Perdue and the U.S. Agriculture Department's Food Safety and Inspection Service, the recall covers select lots of three product...

Our big story this week is from AMD. They're opening up their wallet to the tune of nearly $5 billion to buy ZT Systems. The two companies have had a preexisting partnership, with ZT having collaborated on the EPYC processor lines. ZT's biggest customers are AWS and Azure, as ZT specializes in hyperscale AI systems that are bought by the rack. This move follows a very recent acquisition of Silo AI, which we covered on the Rundown, as well as their last big acquisition of Xilinx. There's a lot to unpack here and the Futurum Group has had some amazing coverage of this deal so far. Stephen, let's start with you. What does ZT Systems have that makes them so attractive to AMD. Time Stamps: 0:00 - Welcome to the Rundown 1:48 - Morpheus Data Acquired by HPE 5:31 - Launchable Acquired by CloudBees 8:26 - Kioxia Reveals Broadband SSD 12:43 - DigiCert to Acquire Vercara to Expand Security Portfolio 16:25 - Western Digital Races Past NetApp with All-Flash OpenFlex 20:11 - Massive Data Leak From Plaintext Passwords 24:34 - ZT Systems to be Acquired by AMD 40:15 - The Weeks Ahead 42:19 - Thanks for Watching Hosts: Tom Hollingsworth: https://www.twitter.com/NetworkingNerd Stephen Foskett: https://www.twitter.com/SFoskett Follow Gestalt IT Website: https://www.GestaltIT.com/ Twitter: https://www.twitter.com/GestaltIT LinkedIn: https://www.linkedin.com/company/Gestalt-IT Tags: #Rundown, #CyberSecurity, #EPYC, @AMD, @ZTSystems, @WesternDigital, @NetApp, @DigiCert, @Vercara, @Kioxia, @Launchable, @CloudBees, @MorpheusData, @HPE, @GestaltIT, @TechFieldDay, @TheFuturmGroup, @Sfoskett, @NetworkingNerd,

AMD wil met een overname ter waarde van bijna vijf miljard dollar een slag slaan in de strijd tegen Nvidia. Joe van Burik vertelt erover in deze Tech Update. AMD, oftewel Advanced Micro Devices, wil voor omgerekend 4,4 miljard euro ZT Systems overnemen, dat zich specialiseert in dataclusters voor bedrijven. Dat betekent dat bedrijven die AI-systemen ontwikkelen en uitrollen, dat zo sneller kunnen doen. ZT is geen bekend bedrijf, maar is al vijftien jaar actief en draait jaarlijks 10 miljard dollar omzet. ZT Systems levert trouwens ook cloud-computer-systemen die zich niet beperken tot AI, maar daar wil AMD na deze overname eigenlijk van af, meldt Reuters. Als die divisie wordt afgestoten, gaat daarmee ook het gros van het personeel weg. Er blijven dan maar duizend van de 2.500 mensen bij ZT Systems over. Verder in deze Tech Update: Supermarktketen Boni heeft te kampen met een cyberaanval, waarbij 16 GB aan financiële gegevens, persoonsgegevens en interne bedrijfsbestanden gestolen zouden zijn OpenAI heeft laten weten dat de gesloten betatest van SearchGPT vol zit, daar nemen nu tienduizend mensen aan deel See omnystudio.com/listener for privacy information.

#Podcast #Samsung #BitCar Un episodio nuevo todos los miércoles y viernes, con Aura López, Javier Matuk y José Antonio Pontón. Puedes seguirlos de manera independiente en Instagram: @aurav @jmatuk y @japonton. ========================

Why does We Knife love speed holes? Why is ZT proudly underbuilt? Find out here. --- Support this podcast: https://podcasters.spotify.com/pod/show/everyday-city-carry/support

On the mid-week supplemental episode of The Knife Junkie podcast (episode 492), Bob "The Knife Junkie" DeMarco looks at some of his knives that are smooth on washers (We Don't Need No Stinkin' Bearings!), including the QSP Penguin, Emerson Seax, and the ZT 0640. among others.Bob starts the show with his favorite comment of the week, followed by his pocket check of knives: the Microtech SOCOM Elite, GEC #15, Pinkerton Fire Ant, and the AUX MFG Pocket Bowie (Emotional Support Knife).He also show off the T. Kell Knives Agent-001 Prototype V2 (a TKJ Design).In Knife Life News:• Classic SVORD Peasant Knife Gets Dressed up• James Brand Kline--Now in Molten Carbon Fiber• Numerous Cool Complications on the Latest WE/Torbe• GiantMouse Iona V2Meanwhile, in his State of the Collection, Bob looks at Byrd Cara Cara (Emerson Wave).Find the list of all the knives shown in the show and links to the Knife Life news stories at https://theknifejunkie.com/492.Support the Knife Junkie channel with your next knife purchase. Find our affiliate links at https://theknifejunkie.com/knives. You can also support The Knife Junkie and get in on the perks of being a patron, including early access to the podcast and exclusive bonus content. Visit https://www.theknifejunkie.com/patreon for details.Let us know what you thought about this episode and leave a rating and/or a review. Your feedback is appreciated. You can also call the listener line at 724-466-4487 or email bob@theknifejunkie.com with any comments, feedback, or suggestions.To watch or listen to past episodes of the podcast, visit https://theknifejunkie.com/listen. And for professional podcast hosting, use The Knife Junkie's podcast platform of choice: https://theknifejunkie.com/podhost.

Chris and I cover all kinds of items in this one. Why should we care that there is a ZT certification now from the Cloud Security Alliance? Is that a good thing? What about other certifications? Why is the industry still doing the same stuff and nothing changes? Do the big players muscle out the little guys to the detriment of us all? Those and more on this one!

- You recently wrote a book titled Zero Trust and Third Party Risk. Can you tell us a bit about the book, why you wrote it and how you see the convergence of ZT and TPRM?- There's been a lot of discussion lately around Software Supply Chain Security, but also Cybersecurity Supply Chain Risk Management, or C-SCRM. Do you see the former being part of the latter, and what challenges do you think organizations face trying to tackle both?- TPRM often involves manual subjective lengthy questionnaires that we are all painfully familiar with. How effective do you think these are and do you think we are going to see a future based on machine-readable attestations and more automated assessments to augment some of the traditional manual questionnaire type activities?- Most organizations struggle to implement fundamental security practices and processes within their own organization, let alone thoroughly ensuring all of their 3rd and nth tier suppliers are, is this a gordian knot type situation?- What are your thoughts on first party self-attestations vs 3rd party assessments? Each has its pros and cons and challenges. - The name Zero Trust is a bit of a misnomer, as we know it means no implicit trust, and it also seems a little counter-intuitive in our increasingly inter-connected ecosystem and society. How do you see the push for Zero Trust playing out when we look at the broader supply chain ecosystem?

Rick Moy and I discuss ZT and the cloud. How developers can and should look at security (it's not how you think). Dealing with ethereal assets, 5G and a whole bunch of other great issues in this episode!

Looking at the history and alternative methods of measuring time with and without a complication in a mechanical movement. For full notes, photos, and video links subscribe to Analog Explorer on Substack, and as always with a AE x ZT collab-episode, there will be an extended conversation version on the Zulu Time Podcast feed. There has been a lot of buzz surrounding affordable GMT complications in microbrand watches. On the mic is long-time Analog Explorer alumni  ⁠Dan⁠ ( @Timely_Moments ) from the ⁠Zulu Time Podcast⁠, and in this collaborative episode, we explore how the bezel surrounding GMT movements can enhance their functionality. We cover a brief history of the evolution of bezels and what they measure. And we put out our conjecture that perhaps we may see a revival of simpler bezel designs that allow for different timing options without the added expense and complexity of a mechanical 4-hand movement. Show notes available | https://analogexplorer.substack.com/p/ae-18-bezel-action --- Support this podcast: https://podcasters.spotify.com/pod/show/analogexplorer/support

Zero trust architecture has the potential to improve an enterprise's security posture. There is still considerable uncertainty about the zero trust transformation process, however, as well as how zero trust architecture will ultimately appear in practice. Recent executive orders have accelerated the timeline for zero trust adoption in the federal sector, and many private-sector organizations are following suit. Researchers in the CERT Division at the Carnegie Mellon University Software Engineering Institute (SEI) hosted Zero Trust Industry Days to enable industry stakeholders to share information about implementing zero trust. In this SEI podcast, CERT researchers Matthew Nicolai and Nathaniel Richmond discuss five zero trust best practices identified during the two-day event, explain their significance, and provide commentary and analysis on ways to empower your organization's zero trust transformation. 

The Heilege Chasam Sofer's Zt”l's hardest Mitzva in the Torah?!? Is it better to live in Tel Aviv with the H*m*s*x*als Bar Minan more than in Lakewood!!?! “Don't hate the player hate the game”!!!!!

Samsung is dealing with an insider threat that tried to copy their entire chip manufacturing plant, wow! CISA issued a "binding" directive for ZT, but how binding is it really? The top 10 from the Verizon DBIR, what does that tell us about the space? Another Presidential candidate uses a deepfake to target their adversaries, should we worry? A mother deals with a deepfake voice attack where her daughter is "kidnapped", does this bode well for our collective future if criminals are vectoring in on this type of attack? 99% of organizations expect an identity related compromise this year, jeez (#killthepassword already). Those points and more on this one!

It's In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: after a long wait, the FDA approves Medtronics 780G and lifts their warning letter, Omnipod GO for people with type 2 gets approved, a look at insulin in pill form, a new way to treat overnight low blood sugars and lots more! Please visit our Sponsors & Partners - they help make the show possible! Take Control with Afrezza  Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines happening now XX In the news is brought to you by the T1D Exchange, make your voice heard and drive research that matters XX Buckle up there is a LOT going on XX Medtronic's Minimed 780G AID system gets FDA approval. This is for people aged 7 years and older who have type 1 diabetes. Medtronic will begin taking preorders on May 15, 2023. Users of the current MiniMed 770G will be eligible for free remote software upgrades. The 780G is currently available in 105 countries. It has been available in Europe since 2020 and in the UK since 2021. The biggest difference from other systems is that it can automatically administer bolus correction insulin doses every 5 minutes. It will also automatically adjust basal insulin The insulin pump's infusion set can be worn for 7 days, rather than 3 days as with the older system, and the glucose target level can be set as low as 100 mg/dL. In the pivotal US trial, overall, patients who used the 780G spent 75% of the time in ideal glucose range (70-180 mg/dL) and 1.8% of the time below that range. Overnight, the figures were 82% and 1.5%, respectively. With the glucose target set at 100 mg/dL and active insulin time set to 2 hours, patients spent 78.8% of time in range without increased hyperglycemia. https://www.medscape.com/viewarticle/991091 XX U.S. Food and Drug Administration (FDA) lifted Medtronic's warning letter sent in December 2021. The resolution of the warning letter follows ongoing remediation actions from the company and proactive actions to continue to strengthen its quality systems. All regulatory restrictions associated with the warning letter have been resolved. https://finance.yahoo.com/news/medtronic-diabetes-resolves-warning-letter-203000188.html XX FDA also approved Omipod GO, for people with type 2 who take daily injections of long acting insulin. Insulet says “Omnipod GO was designed to serve the more than three million people using basal insulin or transitioning to insulin therapy to treat their type 2 diabetes” Omnipod GO is a standalone system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. It's tubeless and waterproof just like a regular Omnipod but it's offered in seven different pre-programmed daily rates, ranging from 10 to 40 units per day, and operates without the need for a handheld device to control the Pod. It has been cleared for use with the following U-100 insulins: NovoLog®, Fiasp®, Humalog®, Admelog®, and Lyumjev®. The product was developed to serve people with type 2 diabetes earlier in their treatment journey by starting them on Pod therapy for their insulin delivery, rather than daily injections. If a patient becomes insulin-intensive, meaning they require both basal and bolus insulin, the transition to another Omnipod product would be seamless. Omnipod GO will have its US launch sometime next year. https://www.businesswire.com/news/home/20230424006026/en/Insulet-Announces-FDA-Clearance-of-Omnipod-GO%E2%84%A2-a-First-of-its-Kind-Basal-Only-Insulin-Pod-Further-Simplifying-Life-for-People-with-Type-2-Diabetes XX Senseonics says the first pediatric study participant has received an Eversense 365-day CGM insertion. The E3 180 day implantable CGM got FDA approval in February last year. Dr. Francine Kaufman, Senseonics CMO, said expanding to a pediatric population represents a “priority” for the company. Positive results could further extend the company's reach across the global diabetes community, she added. The company also intends to utilize study data to submit for an integrated CGM (iCGM) designation in 2023. Senseonics holds an FDA investigational device exemption (IDE) to expand the trial to pediatric patients. These patients — between 14 and 18 years old — first enrolled in the second quarter of 2023. https://www.drugdeliverybusiness.com/senseonics-first-pediatric-cgm-insertions/ XX Baqsimi gets a new home. Amphastar Pharmaceuticals is buying the Glucagon nasal spray from Lilly in a deal worth up to $1.08 billion dollars. Launched in 2019, Baqsimi saw worldwide sales worth $139.3 million in 2022, the companies said. You may remember that Lilly had acquired Baqsimi from Locemia Solutions in 2015. The drug has an active compound glucagon, a form of a hormone produced in the pancreas that stimulates glucose production https://www.reuters.com/markets/deals/eli-lilly-sell-low-blood-sugar-drug-amphastar-2023-04-24/ XX The FDA recently cleared a new experimental drug for type 1 diabetes to begin a phase 2 clinical trial. If approved, the drug would be the first therapy to specifically address low blood sugar at night. We've talked about this.. Zucara Therapeutics is testing an oral medication currently known as ZT-01 will attempt to restore the body's natural ability to respond to low blood sugar levels. Researchers will evaluate the ability of the drug to blunt hypoglycemia caused by insulin in type 1 diabetes. This phase 2 clinical trial follows positive results from the company's earlier phase 1 study which included 18 participants with type 1 diabetes who received the treatment. Of these 18, 16 (89%) had a meaningful increase in glucagon production after being given ZT-01, with no serious health events during the trial. https://diatribe.org/drug-prevent-nighttime-lows-approved-enter-clinical-trials XX The T1D Exchange Registry is a research study conducted online over time, designed to foster innovation and improve the lives of people with T1D. The platform is open to both adults and children with T1D living in the U.S. Personal information remains confidential and participation is fully voluntary. Once enrolled, participants will complete annual surveys and have the opportunity to sign up for other studies on specific topics related to T1D. The registry aims to improve knowledge of T1D, accelerate the discovery and development of new treatments and technologies, and generate evidence to support policy or insurance changes that help the T1D community. By sharing opinions, experiences and data, patients can help advance meaningful T1D treatment, care and policy. XX Australian scientists have designed a new way to swallow insulin, in a pill form. The design also has potential uses for delivering other protein drugs, such as antibiotics and cancer treatments. Insulin is made of smaller versions of proteins called peptides. Previous attempts to develop an orally administered insulin have found that the severe pH levels in the gastrointestinal tract degrade the peptides, causing the drug to lose its function. To get around this problem, the scientists encapsulated the insulin in a lipid-based nanomaterial placed inside an enteric capsule. In animal studies, long acting insulin was absorbed better than fast acting. They say long way to go, but an interesting start. https://newatlas.com/medical/new-insulin-capsule-game-changing-diabetics/ XX A new proof of principle study demonstrates the accuracy of Know Labs' proprietary Bio-RFID™ sensor in quantifying different analytes in vitro, proving a 100% accuracy rate in these tests. The full study is currently undergoing the peer-review publishing process. “Proof-of-principle studies are critical in demonstrating Bio-RFID's accuracy for non-invasive methods of medical diagnostics. This was an essential step toward achieving our goal of delivering the first FDA-cleared, truly non-invasive glucose monitoring device to the market” Know Labs' technology platform, Bio-RFID, uses electromagnetic energy in the form of radio waves to non-invasively capture molecular signatures, which can be converted into physiologically meaningful information and insights. While the technology is proven to accurately measure several analytes inside and outside the body, the first application of this technology is aimed at non-invasive glucose monitoring. This study did not include people but researchers say it's an important step on the way. https://www.businesswire.com/news/home/20230421005095/en/Know-Labs-Demonstrates-Accuracy-of-Non-Invasive-Bio-RFID-Technology-with-Proof-of-Principle-Study XX Moms Night Out – new cities include Providence, RI, Frisco, TX and Charlotte NC. more info here XX On the podcast next week.. Dexom's Jake Leach brings us up to date on some G7 updates as well as new Medicare coverage for people with type 2. Last week's episode was with the first US commercial pilot with type 1, Pietro Marsala. . That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Anton Kulikov as market dynamics shift in the wake of the February Fed meeting and the January NFP report.Tune in as they discuss why stocks could trade sideways (/ES, /NQ, /RTY), why bond bears are winning (/ZB, /ZN, /ZT), and why energy markets remain tough for bulls (/CL, /NG).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Anton Kulikov as market dynamics shift in the wake of the February Fed meeting and the January NFP report.Tune in as they discuss why stocks could trade sideways (/ES, /NQ, /RTY), why bond bears are winning (/ZB, /ZN, /ZT), and why energy markets remain tough for bulls (/CL, /NG).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Pete Mulmat about markets after the January US nonfarm payrolls report.Tune in as they discuss why stocks are at key resistance levels (/ES, /NQ), rangebound price action in bonds (/ZT, /ZN, /ZB), and why patience is still needed in energy markets (/CL, /NG).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Pete Mulmat about markets after the January US nonfarm payrolls report.Tune in as they discuss why stocks are at key resistance levels (/ES, /NQ), rangebound price action in bonds (/ZT, /ZN, /ZB), and why patience is still needed in energy markets (/CL, /NG).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Anton Kulikov about trade setups in various asset classes ahead of the February Federal Reserve rate decision.Tune in as they discuss the bullish potential for stocks (/ES, /NQ, /RTY), why bond bulls may soon reemerge (/ZB, /ZN, /ZT), and why the consolidation in precious metals may yield to further gains soon (/GC, /SI).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Anton Kulikov about trade setups in various asset classes ahead of the February Federal Reserve rate decision.Tune in as they discuss the bullish potential for stocks (/ES, /NQ, /RTY), why bond bulls may soon reemerge (/ZB, /ZN, /ZT), and why the consolidation in precious metals may yield to further gains soon (/GC, /SI).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Jermal Chandler about the calm before the storm that is the February Federal Reserve rate decision.Tune in as they discuss the drift higher in equity futures (/ES, /NQ, /RTY, /YM), the small rebound in bonds (/ZT, /ZN, /ZB), and thematic opportunities in FX futures (/6A, /6J).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Jermal Chandler about the calm before the storm that is the February Federal Reserve rate decision.Tune in as they discuss the drift higher in equity futures (/ES, /NQ, /RTY, /YM), the small rebound in bonds (/ZT, /ZN, /ZB), and thematic opportunities in FX futures (/6A, /6J).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Anton Kulikov about the term structure in futures markets around the February Federal Reserve meeting and other event risk this week.Tune in as they discuss updated positioning data per the CFTC's COT report (/ES, /VX, /CL, /GC, /6E), the pullback in US stock futures (/ES, /NQ, /RTY, /YM), and the continued retracement in bonds (/ZT, /ZN, /ZB).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Anton Kulikov about the term structure in futures markets around the February Federal Reserve meeting and other event risk this week.Tune in as they discuss updated positioning data per the CFTC's COT report (/ES, /VX, /CL, /GC, /6E), the pullback in US stock futures (/ES, /NQ, /RTY, /YM), and the continued retracement in bonds (/ZT, /ZN, /ZB).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Jermal Chandler about the rally in risk assets on the heels of the 4Q'22 US GDP report.Tune in as they discuss the push to fresh yearly highs in equity futures (/ES, /NQ), the rangebound conditions in bonds (/ZT, /ZN, /ZB), and energy markets are stuck in a loop (/CL, /NG).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Jermal Chandler about the rally in risk assets on the heels of the 4Q'22 US GDP report.Tune in as they discuss the push to fresh yearly highs in equity futures (/ES, /NQ), the rangebound conditions in bonds (/ZT, /ZN, /ZB), and energy markets are stuck in a loop (/CL, /NG).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Jermal Chandler amid a quieter day of trading on Tuesday ahead of some important earnings reports.Tune in as they discuss the path ahead for stocks (/ES, /NQ), technical reasons why the bond rally may resume (/ZT, /ZN, /ZB), and why gold continues to glitter (/GC).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Jermal Chandler amid a quieter day of trading on Tuesday ahead of some important earnings reports.Tune in as they discuss the path ahead for stocks (/ES, /NQ), technical reasons why the bond rally may resume (/ZT, /ZN, /ZB), and why gold continues to glitter (/GC).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Anton Kulikov about the rally in equity markets after January options expiry on Friday.Tune in as they discuss the gains in US stock futures (/ES, /NQ, /RTY, /YM), the bump higher in US Treasury yields (/ZT, /ZN, /ZB), and whether or not it's still wise to be a gold bull (/GC).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Anton Kulikov about the rally in equity markets after January options expiry on Friday.Tune in as they discuss the gains in US stock futures (/ES, /NQ, /RTY, /YM), the bump higher in US Treasury yields (/ZT, /ZN, /ZB), and whether or not it's still wise to be a gold bull (/GC).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Jermal Chandler as risk appetite continues to deteriorate after its mid-week turn.Tune in as they discuss the drop in stocks (/ES, /NQ), technical reasons why the bond rally may cool (/ZT, /ZN, /ZB), and whether or not precious metals can continue their bull run (/GC, /SI).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Jermal Chandler as risk appetite continues to deteriorate after its mid-week turn.Tune in as they discuss the drop in stocks (/ES, /NQ), technical reasons why the bond rally may cool (/ZT, /ZN, /ZB), and whether or not precious metals can continue their bull run (/GC, /SI).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Anton Kulikov about the deluge of US economic data and news, and the deterioration in risk assets.Tune in as they discuss the reversal in US equities (/ES, /NQ, /RTY, /YM), the rally by bonds to fresh highs (/ZT, /ZN, /ZB), and what to make of FX markets after the BOJ (/6J).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Anton Kulikov about the deluge of US economic data and news, and the deterioration in risk assets.Tune in as they discuss the reversal in US equities (/ES, /NQ, /RTY, /YM), the rally by bonds to fresh highs (/ZT, /ZN, /ZB), and what to make of FX markets after the BOJ (/6J).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Jermal Chandler in the wake of the December US inflation report (CPI).Tune in as they discuss the burgeoning bullish breakout in US equity futures (/ES, /NQ), the returning bid in bond markets (/ZT, /ZN, /ZB), and how to fade the recent rally in energy prices (/CL, /NG).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Jermal Chandler in the wake of the December US inflation report (CPI).Tune in as they discuss the burgeoning bullish breakout in US equity futures (/ES, /NQ), the returning bid in bond markets (/ZT, /ZN, /ZB), and how to fade the recent rally in energy prices (/CL, /NG).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Jermal Chandler after Fed Chair Jerome Powell's speech on Tuesday.Tune in as they discuss the lack of movement in stocks (/ES, /NQ), what to make of price action in energy markets (/CL, /NG), and whether or not the recent bid in bond markets is finished (/ZT, /ZN, /ZB).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Jermal Chandler after Fed Chair Jerome Powell's speech on Tuesday.Tune in as they discuss the lack of movement in stocks (/ES, /NQ), what to make of price action in energy markets (/CL, /NG), and whether or not the recent bid in bond markets is finished (/ZT, /ZN, /ZB).

Christopher Vecchio, CFA, Head of Futures and Forex, talks with Anton Kulikov about future options strategies at the start of the new trading week.Tune in as they discuss the bullish breakout in US equities (/ES, /NQ, /RTY, /YM), the ongoing bid in bonds (/ZT, /ZN, /ZB), and how to structure trades in energy (/CL, /NG).